Bruker CORP Form 4 insider transactions

Frank H Laukien, PRESIDENT & CEO, a Director and 10% owner of Bruker Corp, reported a transaction in 4,838 shares of common stock on August 11, 2026.

Mark Munch, EXEC VP&PRES BRUKER NANO INC. of Bruker Corp, sold 2,000 shares of common stock on July 15, 2026 for $60.25 per share.

Mark Munch of Bruker Corp engaged in a Rule 10b5-1 trading plan, acquiring 2,000 shares at $22.19 and selling 2,000 shares at $54.76 on June 15, 2026.

Bruker Corporation director Thierry Bernard was granted 2,886 restricted stock units as part of his compensation package.

Bruker Corporation executive Mark Munch sold 2,000 shares of common stock for $43.90 each, totaling $87,800, as part of a pre-arranged 10b5-1 trading plan.

Mark Munch, Executive VP of Bruker Nano, exercised 2,000 stock options and sold the resulting shares via a 10b5-1 plan.

Mark Munch, Bruker's Executive VP, exercised options and sold 2,000 shares of common stock for $35.44 per share under a pre-arranged 10b5-1 trading plan.

Mark Munch, Executive VP and President of Bruker Nano Inc., exercised stock options and subsequently sold 2,000 shares of Bruker Corp. common stock.

A Bruker Corporation executive exercised stock options and subsequently sold an equal number of shares under a pre-arranged trading plan.

Mark Munch, Bruker Nano Inc. Executive VP & President, exercised stock options and subsequently sold the acquired shares under a pre-arranged 10b5-1 trading plan.

Bruker Corp. Director Richard A. Packer exercised stock options and subsequently sold a portion of the acquired common stock on December 1, 2025.

A Bruker Corporation director exercised stock options and subsequently sold a portion of the acquired shares on November 6, 2025.

Bruker Corporation Director Cynthia M. Friend exercised stock options and subsequently sold a portion of the acquired shares on September 12, 2025.

Bruker Corp's President and CEO, Frank H. Laukien, was granted 48,431 Restricted Stock Units and 137,339 stock options on August 15, 2025.

Bruker Corporation's President of BIOSPIN Group, Falko Busse, was granted Restricted Stock Units and Stock Options.

Bruker Corp's Executive VP and President of Bruker Nano Inc., Mark Munch, was granted 23,631 Restricted Stock Units and 22,337 stock options.

Bruker Corporation's CFO, Gerald N. Herman, was granted 25,844 Restricted Stock Units and 24,430 stock options, effective August 15, 2025, as part of executive compensation.

Bruker Corporation's President & CEO of Bruker BEST, Burkhard Prause, was granted 5,298 restricted stock units and 5,008 stock options.

Mark Munch, an Executive VP at Bruker Corp, reported the disposal of shares to cover tax obligations related to restricted stock unit vesting.

Bruker Corp's President and CEO, Frank H. Laukien, reported the disposition of shares to cover tax obligations related to restricted stock unit vesting.

Bruker Corporation's Executive Vice President and CFO, Gerald N. Herman, reported routine dispositions of common stock to cover tax obligations from RSU vesting.

Bruker Corporation's President and CEO, Frank H. Laukien, reported a disposition of 3,582 common shares to cover tax obligations related to restricted stock unit vesting.

Bruker Corporation Executive Vice President Mark Munch disposed of 844 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Bruker Corporation's CFO, Gerald N. Herman, reported a disposition of 577 common shares to cover tax obligations related to restricted stock unit vesting.

Bruker Corporation's President and CEO, Frank H. Laukien, has increased his direct beneficial ownership in the company by purchasing 2,608 shares of common stock for approximately $100,000.

Director Laura Francis reports the acquisition of 4,498 Restricted Stock Units (RSUs) of Bruker Corp, vesting on May 15, 2026, convertible to common stock.

Director John Ornell exercised stock options to acquire 5,000 shares of Bruker Corp common stock at $18.15 per share.

William A. Linton, a director of Bruker Corp, exercised stock options to acquire 10,000 shares of common stock at $24 per share on April 22, 2025.

Bruker Corporation's Chief Accounting Officer, Thomas Bures, reports the acquisition of 500 shares of common stock at a price of $47.395 per share on March 10, 2025.

Chief Accounting Officer Thomas Bures reports the acquisition of 2,972 shares of Bruker Corp common stock through restricted stock units.